Antiemetics and IBD Tx Flashcards
-setrons (dolasetron, granisetron, ondansetron, palonosetron) MOA TU Tox
-setrons
MOA: 5-HT3 antagonists in central vomiting center and periphery
TU: acute phase chemo rxn, post-op and -radiation
Tox: constipation, dizziness, headache, subclinical QT elongation
Scopolamine
MOA
PK
scopolamine
MOA: mAChR antagonist, dopamine antagonist (esp in cerebellum)
PK: total CNS distribution, transdermal patch
Dimenhydrinate, diphenhydramine, meclizine
MOA
Tox
H1 antagonists
MOA: sedation, some mAChR antagonist
Tox: anti-mAChR, Abx interaction, not for pregnancy
Droperidol, metoclopramide, procholorperazine, promethazine, thiethylperazine
MOA
MOA: D2 antagonists in chemo-trigger zone, anti-muscarinic
Dronabinol
MOA
TU
Tox
dronabinol
MOA: central canibinoid receptors (sedation)
TU: chemo, co-Tx w/ phenothiazines
Tox: euphoria, sedation, hallucinations, dry mouth, increased appetite
Nabilone
MOA
TU
Tox
nabilone
MOA: central canibinoid receptors (sedation)
TU: chemo, co-Tx w/ phenothiazines
Tox: euphoria, sedation, hallucinations, dry mouth, increased appetite
Dexamethasone, methylprednisalone
MOA
corticosteroids
MOA: unknown in anti-emesis
Balsalazide, mesalamine, solsalazine, sulfasalazine
MOA
TU
Tox
Balsalazide, mesalamine, solsalazine, sulfasalazine
MOA: gut bacteria release R group, release ASA only in gut. only active in intestines after activation (not stomach)
TU: ulcerative colitis 1st line, not Crohn’s–high high []
Tox: sulfasalazine–hypersensitivity, BM suppression, folate uptake inhibition
Budesonide
MOA
TU
budesonide
MOA: corticosteroid
TU: Crohn’s, extensive 1st pass metabolism
Infliximab MOA PK TU Tox
infliximab
MOA: TNF-α antibody, helps in dysregulation of Th1 cells and activates complement
PK: 1/3 develop Ab to infliximab –> refractory
TU: Crohn’s
Tox: infections, TB reactivation, increased lymphoma risk, hepatotox